23 May 2013
Keywords: medarex, mdx-33, plasma, protein, leader, centeon, agreed
Article | 13 May 1996
- Plasma protein leader Centeon and Medarex have agreed to develop
jointly Medarex' MDX-33, a humanized monoclonal antibody for the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
22 May 2013
© 2013 thepharmaletter.com